share_log

TYRA BIOSCIENCES, INC. | 8-K: Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights

SEC announcement ·  Mar 20 04:11
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.